Cargando…

Evidence for a lack of inotropic and chronotropic effects of glucagon and glucagon receptors in the human heart

BACKGROUND: Glucagon is thought to increase heart rate and contractility by stimulating glucagon receptors and increasing 3′,5′-cyclic adenosine monophosphate (cAMP) production in the myocardium. This has been confirmed in animal studies but not in the human heart. The cardiostimulatory effects of g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aranda-Domene, Ramón, Orenes-Piñero, Esteban, Arribas-Leal, José María, Canovas-Lopez, Sergio, Hernández-Cascales, Jesús
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230788/ https://www.ncbi.nlm.nih.gov/pubmed/37254135 http://dx.doi.org/10.1186/s12933-023-01859-8

Ejemplares similares

Does glucagon have a positive inotropic effect in the human heart?
por: Hernández-Cascales, Jesus
Publicado: (2018)

Possible mechanism of inotropic and chronotropic effects of Rosa damascena on isolated guinea pig heart
por: Boskabady, Mohammad Hossein, et al.
Publicado: (2013)

Chronotropic, Inotropic and Dromotropic Parameters of the Heart and Oxidative Stress in Rats Receiving High Doses of Fructose
por: Radmanesh, Esmat, et al.
Publicado: (2019)

Glucagon Increases Beating Rate but Not Contractility in Rat Right Atrium. Comparison with Isoproterenol
por: Merino, Beatriz, et al.
Publicado: (2015)

Co-administration of Apelin and T4 Protects Inotropic and Chronotropic Changes Occurring in Hypothyroid Rats
por: Akhondali, Zahra, et al.
Publicado: (2015)

Sensitivity Analysis of Vagus Nerve Stimulation Parameters on Acute Cardiac Autonomic Responses: Chronotropic, Inotropic and Dromotropic Effects
por: Ojeda, David, et al.
Publicado: (2016)

Glucagon Receptor Signaling and Glucagon Resistance
por: Janah, Lina, et al.
Publicado: (2019)

Negative chronotropic and inotropic effects of lubiprostone on iPS cell-derived cardiomyocytes via activation of CFTR
por: Akita, Hiraku, et al.
Publicado: (2020)

Resveratrol enhances the inotropic effect but inhibits the proarrhythmic effect of sympathomimetic agents in rat myocardium
por: Hernandez-Cascales, Jesús
Publicado: (2017)

Glucagon signaling in the heart: Activation or inhibition?()
por: Pocai, Alessandro
Publicado: (2014)

Glucagon and Its Receptors in the Mammalian Heart
por: Neumann, Joachim, et al.
Publicado: (2023)

Evaluation of commercially available glucagon receptor antibodies and glucagon receptor expression
por: Bomholt, Anna Billeschou, et al.
Publicado: (2022)

Stability of glucagon-like peptide 1 and glucagon in human plasma
por: Wewer Albrechtsen, Nicolai J, et al.
Publicado: (2015)

Going further of mitral ring annuloplasty: the role of surgery in atrial functional mitral regurgitation
por: Aranda-Domene, Ramón, et al.
Publicado: (2023)

Novel cilostamide analogs, phosphodiesterase 3 inhibitors, produce positive inotropic but differential lusitropic and chronotropic effects on isolated rat atria
por: Hosseini, Azar, et al.
Publicado: (2017)

Glucagon : its role in physiology and clinical medicine
Publicado: (1977)

Beginning of a new era in glucagon research: Breakthrough by the new glucagon assay
por: Kawamori, Dan
Publicado: (2020)

Revisiting the Pharmacological Value of Glucagon: An Editorial for the Special Issue “The Biology and Pharmacology of Glucagon”
por: Müller, Timo D., et al.
Publicado: (2020)

Computational Peptide Design Cotargeting Glucagon and Glucagon-like Peptide-1 Receptors
por: Vishnoi, Shubham, et al.
Publicado: (2023)

Temperature alters the inotropic, chronotropic and proarrhythmic effects of histamine in atrial muscle preparations from humans and H(2)-receptor overexpressing mice
por: Hoffmann, Robert J. R., et al.
Publicado: (2023)

Glucagon Effects on Ischemic Vasodilatation in the Isolated Rat Heart
por: Rosic, Mirko, et al.
Publicado: (2010)

Glucagon and heart in type 2 diabetes: new perspectives
por: Ceriello, Antonio, et al.
Publicado: (2016)

Glucagon Receptor Antagonism Ameliorates Progression of Heart Failure
por: Gao, Chen, et al.
Publicado: (2019)

Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
por: Pocai, Alessandro, et al.
Publicado: (2009)

Recent Progress in the Use of Glucagon and Glucagon Receptor Antago-nists in the Treatment of Diabetes Mellitus
por: Lotfy, Mohamed, et al.
Publicado: (2014)

Intraperitoneal and subcutaneous glucagon delivery in anaesthetized pigs: effects on circulating glucagon and glucose levels
por: Åm, Marte Kierulf, et al.
Publicado: (2020)

Disruption of the glucagon receptor increases glucagon expression beyond α-cell hyperplasia in zebrafish
por: Kang, Qi, et al.
Publicado: (2022)

Glucagon receptor antagonism impairs and glucagon receptor agonism enhances triglycerides metabolism in mice
por: Galsgaard, Katrine D., et al.
Publicado: (2022)

Oxyntomodulin increases intrinsic heart rate through the glucagon receptor
por: Mukharji, Auyon, et al.
Publicado: (2013)

Modulation of Glucagon Signaling: A Metabolic Approach for Heart Failure?
por: Pocai, Alessandro
Publicado: (2019)

Copeptin under glucagon stimulation
por: Lewandowski, Krzysztof C., et al.
Publicado: (2015)

Insulin and Glucagon: Partners for Life
por: Holst, Jens Juul, et al.
Publicado: (2017)

Glucagon contributes to liver zonation
por: Cheng, Xiping, et al.
Publicado: (2018)

Metabolic effects of glucagon in humans
por: Adeva-Andany, María M., et al.
Publicado: (2018)

Glucagon, GLP-1 and Thermogenesis
por: González-García, Ismael, et al.
Publicado: (2019)

Glucagon Regulation of Energy Expenditure
por: Kleinert, Maximilian, et al.
Publicado: (2019)

Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes
por: Sherr, Jennifer L., et al.
Publicado: (2016)

Increased biogenesis of glucagon-containing secretory granules and glucagon secretion in BIG3-knockout mice
por: Li, Hongyu, et al.
Publicado: (2015)

Misrouting of glucagon and stathmin-2 towards lysosomal system of α-cells in glucagon hypersecretion of diabetes
por: Asadi, Farzad, et al.
Publicado: (2021)

Single-molecule analysis reveals that a glucagon-bound extracellular domain of the glucagon receptor is dynamic
por: Liu, Ting, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_62u2r48qheoro1us07d06km255